Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 53

1.

Resolvin D1 promotes the targeting and clearance of necroptotic cells.

Gerlach BD, Marinello M, Heinz J, Rymut N, Sansbury BE, Riley CO, Sadhu S, Hosseini Z, Kojima Y, Tang DD, Leeper NJ, Spite M, Barroso M, Rayner KJ, Fredman G.

Cell Death Differ. 2019 Jun 20. doi: 10.1038/s41418-019-0370-1. [Epub ahead of print]

PMID:
31222041
2.

Delivery of MicroRNAs by Chitosan Nanoparticles to Functionally Alter Macrophage Cholesterol Efflux in Vitro and in Vivo.

Nguyen MA, Wyatt H, Susser L, Geoffrion M, Rasheed A, Duchez AC, Cottee ML, Afolayan E, Farah E, Kahiel Z, Côté M, Gadde S, Rayner KJ.

ACS Nano. 2019 Jun 25;13(6):6491-6505. doi: 10.1021/acsnano.8b09679. Epub 2019 Jun 12.

PMID:
31125197
3.

Anti-GRP78 autoantibodies induce endothelial cell activation and accelerate the development of atherosclerotic lesions.

Crane ED, Al-Hashimi AA, Chen J, Lynn EG, Won KD, Lhoták Š, Naeim M, Platko K, Lebeau P, Byun JH, Shayegan B, Krepinsky JC, Rayner KJ, Marchiò S, Pasqualini R, Arap W, Austin RC.

JCI Insight. 2018 Dec 20;3(24). pii: 99363. doi: 10.1172/jci.insight.99363.

4.

Collagen biomaterial stimulates the production of extracellular vesicles containing microRNA-21 and enhances the proangiogenic function of CD34+ cells.

McNeill B, Ostojic A, Rayner KJ, Ruel M, Suuronen EJ.

FASEB J. 2019 Mar;33(3):4166-4177. doi: 10.1096/fj.201801332R. Epub 2018 Dec 7.

PMID:
30526047
5.

Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions.

Raggi P, Genest J, Giles JT, Rayner KJ, Dwivedi G, Beanlands RS, Gupta M.

Atherosclerosis. 2018 Sep;276:98-108. doi: 10.1016/j.atherosclerosis.2018.07.014. Epub 2018 Jul 25. Review.

PMID:
30055326
6.

PAR2 (Protease-Activated Receptor 2) Deficiency Attenuates Atherosclerosis in Mice.

Jones SM, Mann A, Conrad K, Saum K, Hall DE, McKinney LM, Robbins N, Thompson J, Peairs AD, Camerer E, Rayner KJ, Tranter M, Mackman N, Owens AP 3rd.

Arterioscler Thromb Vasc Biol. 2018 Jun;38(6):1271-1282. doi: 10.1161/ATVBAHA.117.310082. Epub 2018 Mar 29.

7.

Extracellular Vesicles Secreted by Atherogenic Macrophages Transfer MicroRNA to Inhibit Cell Migration.

Nguyen MA, Karunakaran D, Geoffrion M, Cheng HS, Tandoc K, Perisic Matic L, Hedin U, Maegdefessel L, Fish JE, Rayner KJ.

Arterioscler Thromb Vasc Biol. 2018 Jan;38(1):49-63. doi: 10.1161/ATVBAHA.117.309795. Epub 2017 Sep 7.

8.

Paradoxical Suppression of Atherosclerosis in the Absence of microRNA-146a.

Cheng HS, Besla R, Li A, Chen Z, Shikatani EA, Nazari-Jahantigh M, Hammoutène A, Nguyen MA, Geoffrion M, Cai L, Khyzha N, Li T, MacParland SA, Husain M, Cybulsky MI, Boulanger CM, Temel RE, Schober A, Rayner KJ, Robbins CS, Fish JE.

Circ Res. 2017 Aug 4;121(4):354-367. doi: 10.1161/CIRCRESAHA.116.310529. Epub 2017 Jun 21.

9.

Cell Death in the Vessel Wall: The Good, the Bad, the Ugly.

Rayner KJ.

Arterioscler Thromb Vasc Biol. 2017 Jul;37(7):e75-e81. doi: 10.1161/ATVBAHA.117.309229. Review. No abstract available.

10.

microRNA-33 Regulates Macrophage Autophagy in Atherosclerosis.

Ouimet M, Ediriweera H, Afonso MS, Ramkhelawon B, Singaravelu R, Liao X, Bandler RC, Rahman K, Fisher EA, Rayner KJ, Pezacki JP, Tabas I, Moore KJ.

Arterioscler Thromb Vasc Biol. 2017 Jun;37(6):1058-1067. doi: 10.1161/ATVBAHA.116.308916. Epub 2017 Apr 20.

11.

MicroRNAs in the Pathobiology and Therapy of Atherosclerosis.

Laffont B, Rayner KJ.

Can J Cardiol. 2017 Mar;33(3):313-324. doi: 10.1016/j.cjca.2017.01.001. Epub 2017 Jan 5. Review.

12.

The walking dead: macrophage inflammation and death in atherosclerosis.

Kavurma MM, Rayner KJ, Karunakaran D.

Curr Opin Lipidol. 2017 Apr;28(2):91-98. doi: 10.1097/MOL.0000000000000394. Review.

13.

A big shot of small RNAs repairs a broken heart.

Rayner KJ.

Sci Transl Med. 2017 Jan 25;9(374). pii: eaal4999. doi: 10.1126/scitranslmed.aal4999.

PMID:
28123072
14.

LDL cholesterol hitches a ride.

Rayner KJ.

Sci Transl Med. 2016 Dec 7;8(368):368ec196. No abstract available.

PMID:
27928022
15.

Nanomedicine Meets microRNA: Current Advances in RNA-Based Nanotherapies for Atherosclerosis.

Gadde S, Rayner KJ.

Arterioscler Thromb Vasc Biol. 2016 Sep;36(9):e73-9. doi: 10.1161/ATVBAHA.116.307481. Review.

16.

Targeting macrophage necroptosis for therapeutic and diagnostic interventions in atherosclerosis.

Karunakaran D, Geoffrion M, Wei L, Gan W, Richards L, Shangari P, DeKemp EM, Beanlands RA, Perisic L, Maegdefessel L, Hedin U, Sad S, Guo L, Kolodgie FD, Virmani R, Ruddy T, Rayner KJ.

Sci Adv. 2016 Jul 22;2(7):e1600224. doi: 10.1126/sciadv.1600224. eCollection 2016 Jul.

17.

How Biomaterials Can Influence Various Cell Types in the Repair and Regeneration of the Heart after Myocardial Infarction.

Lister Z, Rayner KJ, Suuronen EJ.

Front Bioeng Biotechnol. 2016 Jul 18;4:62. doi: 10.3389/fbioe.2016.00062. eCollection 2016. Review.

18.

Long Noncoding RNAs in the Heart: The Regulatory Roadmap of Cardiovascular Development and Disease.

Rayner KJ, Liu PP.

Circ Cardiovasc Genet. 2016 Apr;9(2):101-3. doi: 10.1161/CIRCGENETICS.116.001413. No abstract available.

PMID:
27094196
19.

Mycobacterium tuberculosis induces the miR-33 locus to reprogram autophagy and host lipid metabolism.

Ouimet M, Koster S, Sakowski E, Ramkhelawon B, van Solingen C, Oldebeken S, Karunakaran D, Portal-Celhay C, Sheedy FJ, Ray TD, Cecchini K, Zamore PD, Rayner KJ, Marcel YL, Philips JA, Moore KJ.

Nat Immunol. 2016 Jun;17(6):677-86. doi: 10.1038/ni.3434. Epub 2016 Apr 18.

20.

miRNA Targeting of Oxysterol-Binding Protein-Like 6 Regulates Cholesterol Trafficking and Efflux.

Ouimet M, Hennessy EJ, van Solingen C, Koelwyn GJ, Hussein MA, Ramkhelawon B, Rayner KJ, Temel RE, Perisic L, Hedin U, Maegdefessel L, Garabedian MJ, Holdt LM, Teupser D, Moore KJ.

Arterioscler Thromb Vasc Biol. 2016 May;36(5):942-951. doi: 10.1161/ATVBAHA.116.307282. Epub 2016 Mar 3.

Supplemental Content

Loading ...
Support Center